US Stock MarketDetailed Quotes
VXLLF VAXIL BIO LTD (CA)
- 0.005300
- 0.0000000.00%
15min DelayTrading Apr 18 16:00 ET
725.99KMarket Cap-757P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.005300Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)136.98MShares0.06000052wk High1.06P/B725.99KFloat Cap0.00210052wk Low--Dividend TTM136.98MShs Float0.128300Historical High--Div YieldTTM0.00%Amplitude0.002100Historical Low--Avg Price1Lot Size
VAXIL BIO LTD (CA) Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 68.59%-49K | -140.52%-279K | 41.22%-164K | 32.29%-734K | -37.59%-183K | 47.83%-156K | 62.34%-116K | 18.90%-279K | 14.44%-1.08M | 70.90%-133K |
| Net income from continuing operations | 79.86%-28K | 13.01%-127K | 0.79%-125K | 40.77%-584K | 38.21%-173K | 41.84%-139K | 30.14%-146K | 51.16%-126K | 27.39%-986K | 51.30%-280K |
| Depreciation and amortization | --0 | --0 | --0 | -92.00%2K | --0 | --0 | --0 | -66.67%2K | -56.14%25K | 54.55%17K |
| Change In working capital | -7.41%-29K | -631.03%-154K | 72.44%-43K | 12.44%-169K | -111.54%-15K | 65.38%-27K | 125.22%29K | -20.00%-156K | -51.97%-193K | 88.41%130K |
| -Change in receivables | 45.45%16K | -137.50%-38K | 0.00%11K | -86.59%11K | 25.00%5K | 650.00%11K | -150.00%-16K | -77.08%11K | 184.54%82K | 105.33%4K |
| -Change in payables and accrued expense | -18.42%-45K | -357.78%-116K | 67.66%-54K | 34.55%-180K | -115.87%-20K | 50.00%-38K | 130.61%45K | 6.18%-167K | -816.67%-275K | -12.50%126K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 68.59%-49K | -140.52%-279K | 41.22%-164K | 32.29%-734K | -37.59%-183K | 47.83%-156K | 62.34%-116K | 18.90%-279K | 14.44%-1.08M | 70.90%-133K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | -29.29%1.81M | -96.48%35K | |||||||
| Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 57.14%-9K | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -0.33%1.82M | -89.86%35K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -29.29%1.81M | -96.48%35K |
| Net cash flow | ||||||||||
| Beginning cash position | -42.30%1.06M | -31.53%1.34M | -32.62%1.51M | 48.41%2.24M | -27.56%1.69M | -29.99%1.84M | -33.60%1.96M | 48.41%2.24M | 1,719.28%1.51M | 198.97%2.33M |
| Current changes in cash | 68.59%-49K | -140.52%-279K | 41.22%-164K | -201.38%-734K | -86.73%-183K | 47.83%-156K | 62.34%-116K | -119.52%-279K | -43.88%724K | -118.25%-98K |
| Effect of exchange rate changes | -100.00%-6K | --1K | -100.00%-4K | -57.14%3K | -38.46%8K | 66.67%-3K | --0 | -115.38%-2K | 125.93%7K | -58.06%13K |
| End cash Position | -40.12%1.01M | -42.30%1.06M | -31.53%1.34M | -32.62%1.51M | -32.62%1.51M | -27.56%1.69M | -29.99%1.84M | -33.60%1.96M | 66.49%2.24M | 66.49%2.24M |
| Free cash flow | 68.59%-49K | -140.52%-279K | 41.22%-164K | 32.29%-734K | -37.59%-183K | 47.83%-156K | 62.34%-116K | 18.90%-279K | 14.44%-1.08M | 70.90%-133K |
| Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg